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Abstract 1 
 2 
The antimicrobial activity of a regular and decaffeinated Arabica coffee extract was evaluated 3 
against three different Gram-positive bacteria and two Gram-negatives, including pathogenic 4 
Staphylococci strains. The antimicrobial activity was shown to be independent from caffeine 5 
content and was more pronounced against the Gram-positive strains. The regular coffee extract 6 
exhibited a significant bacteriostatic effect against Staphylococcus aureus and Staphylococcus 7 
epidermidis at short exposure times and became bactericidal after prolonged exposure. The 8 
potential cytotoxicity of the regular coffee extract was also evaluated towards breast 9 
adenocarcinoma MCF7 cells, showing to become significant only after 24 h exposure and at a 10 
higher concentration than that producing the antibacterial effect. These results highlight the 11 
potential of a coffee extract as a naturally active antibacterial component for topical use such as for 12 
hand washing preparations to be used in health care units.  13 
 14 
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Abbreviations 17 
 18 
MH, Mueller-Hinton broth; CQAs, caffeoylquinic acids; FQAs, ferruoylquinic acids; UHPLC, 19 
Ultra High Performance Liquid Chromatography; MIC, minimum inhibitory concentration; MBC, 20 
minimum bactericidal concentration; FIC, fractional inhibitory concentration; DMEM, Dulbecco’s 21 
modified Eagle’s medium; FBS, fetal bovine serum; PBS, phosphate buffered saline; MTT, 1-(4, 5-22 
Dimethylthiazol-2-yl)-3, 5-diphenylformazan; MRSA, methicillin-resistant S. aureus. 23 
24 
 3 
1. Introduction 25 
 26 
The increase in the antimicrobial resistance in bacterial populations raises the question of an urgent 27 
response in terms of new antimicrobial molecules (Zell & Goldmann, 2007). However the 28 
development of new antibiotic molecules takes a long time scale and is expensive both in terms of 29 
human and financial resources, therefore the preferred strategy is to optimize already existing 30 
antimicrobial drugs or to combine multiple antibiotic compounds to improve their antimicrobial 31 
potency. Furthermore, the overwhelming concern of the society over the safety of the synthetic 32 
molecules has lead to an increased interest towards molecules of natural origin.  33 
Some studies have reported antimicrobial property for coffee (Almeida, Farah, Silva, Nunan, & 34 
Gloria, 2006; Daglia et al., 2007; Rurian-Henares & Morales, 2008; Tiwari et al., 2009), however 35 
the antibacterial components responsible for the activity and the mechanisms of action have not 36 
been fully elucidated yet (Mueller, Sauer, Weigel, Pichner, & Pischetsrieder, 2011). Previous 37 
studies with Staphylococcus aureus ATCC 25923 and Escherichia coli ATCC 25922 showed that 38 
the antimicrobial potential of coffee is related to the roasting procedure and is dependent on the 39 
degree of roasting, focusing the attention on the products of the Maillard reaction as potentially 40 
responsible for the observed antimicrobial activity (Daglia, Cuzzoni, & Dacarro, 1994). In line with 41 
this hypothesis, antimicrobial activities of melanoidins isolated from coffee have been reported 42 
(Rurian-Henares & Morales, 2008). However, due to the extremely variable composition of these 43 
molecules, derived from carbohydrates, proteins/amino acids and phenolic compounds formed 44 
during the roasting procedure (Bekedam, Loots, Schols, Van Boekel, & Smit, 2008), the exact 45 
mechanism by which the antimicrobial effect takes place remains difficult to elucidate.  46 
Rufiàn-Henares and Morales showed that a coffee fraction, corresponding to high molecular weight 47 
molecules such as melanoidins, was able to disrupt at the minimum inhibitory concentration both 48 
the inner and outer membrane of an E. coli strain, leading to the release of intracellular molecules 49 
(Rurian-Henares & Morales, 2008). Moreover, metal chelating properties were proposed as an 50 
 4 
important feature to mediate the antibacterial activity of coffee (Rufian-Henares & de la Cueva, 51 
2009).  52 
To extend the use of coffee derivatives as antibacterial compounds for topical use, as active 53 
components of hand washing preparations, it is essential to unravel the mechanisms mediating their 54 
antimicrobial properties and to broaden the number of tested strains to define their spectrum of 55 
activity. In this respect, Staphylococcus epidermidis and Enterococcus faecalis are two bacterial 56 
species which have not been extensively tested in the past. The first is the dominant species among 57 
the resident flora on hands  (Rayan & Flournoy, 1987) and is one of the two most frequent cause of 58 
nosocomial infection, together with Staphylococcus aureus (National Nosocomial Infections 59 
Surveillance System, 2004). On the other hand E. faecalis is responsible of nosocomial infections 60 
such as urinary tract and abdominal infections, bacteremia and endocarditis in patients with severe 61 
concomitant diseases or with an impaired immune system (Mundy, Sahm, & Gilmore, 2000). 62 
Contrary to what is observed for the antimicrobial effects of coffee extracts, less is known about its 63 
potential cytotoxicity. Hegele et al. showed that the major cytotoxic component in Maillard reaction 64 
mixtures and coffee (prepared as filter coffee and espresso) is represented by hydrogen peroxide 65 
which is formed through an autooxidative process where polyphenolics reduce atmospheric oxygen 66 
in the presence of transition metals (Hegele, Munch, & Pischetsrieder, 2009).  67 
The aim of the present study was to investigate the antimicrobial activity of Arabica coffee extracts 68 
against bacterial species such as Staphylococcus epidermidis and Enterococcus faecalis, which have 69 
not been extensively studied in the past, and to assay  possible cytotoxicity of the extracts towards 70 
eukaryotic cells. Results are useful to evaluate the potentiality of the extracts as antimicrobials to be 71 
used in topical preparations.  72 
73 
 5 
2. Materials and methods  74 
 75 
2.1. Bacterial strains, media and growth conditions  76 
The bacterial strains used were from the American Type Culture Collection (ATCC) and included 77 
the three Gram-positive cocci Staphylococcus aureus ATCC25923, Staphylococcus epidermidis 78 
ATCC12228 and Enterococcus faecalis 29212, and the two Gram-negative bacilli Escherichia coli 79 
ATCC25922 and Salmonella enterica ATCC14028. Bacterial cultures were grown in Mueller-80 
Hinton (MH) broth (Difco Laboratories, Becton Dickinson and Company, Sparks, MD) at 37°C 81 
under aerobic conditions. 82 
  83 
2.2. Preparation of the regular and decaffeinated total coffee extracts  84 
Regular and decaffeinated coffee extracts were prepared starting from 6 g coffee powder (100% 85 
Arabica, medium roasted), previously defatted by extraction with penthane, by solid-liquid 86 
extraction under continuous stirring with 100 ml boiling water 10 min at 100°C. The aqueous 87 
extracts were centrifuged 10 min at 1600 × g and the clear supernatant was then filtered through 88 
0.45 μm filter and subsequently through 0.22 μm filter. Aliquots of the obtained coffee extracts 89 
were freeze-dried and stored at -20°C until used. The average extraction yields were around 25% 90 
(w/w).  91 
 92 
2.3. Chemicals  93 
Caffeine, trigonelline, formic acid, acetonitrile and methanol were purchased from Sigma-Aldrich 94 
(Steinheim am Albuch, Germany); 5-, 4- and 3-caffeoylquinic acid (CQAs) and 3,4- 3,5- and 4,5-95 
dicaffeoylquinic acid were purchased from Phytolab GmbH & Co. KG (Vestenbergsgreuth, 96 
Germany); ferruoylquinic acids (FQAs) were obtained from the division of organic chemistry and 97 
biochemistry at Ruder Bošković Institute (Zagreb, Croatia) (Dokli, Navarini, & Hamersak, 2013). 98 
 6 
Numbering of substituted position on CQAs and FQAs was designated according to the IUPAC 99 
system. Water was purified on a Milli-Q system from Millipore (Bedford, MA). 100 
 101 
2.4. UHPLC analysis of the coffee extracts  102 
The analysis was performed using a 1290 UHPLC system (Agilent, Waldbronn, Germany), 103 
consisting of a degasser, quaternary pump, thermostated column and diode array detector (DAD) 104 
operating at 254 nm, 272 nm and 324 nm. Samples were prepared by dissolving the lyophilized 105 
powder in a solution of 60% (v/v) methanol in Milli-Q water and then filtered through a 0.22 μm 106 
filter. 2 μl of the sample were injected in the UHPLC system and the flow rate was 1.2 ml/min. For 107 
caffeine, trigonelline and 3-, 4-, 5- chlorogenic acid, determinations were carried out using a 4.6 108 
mm × 150 mm, 2.7 μm 120 SB-C18 Poroshell column (Agilent, Santa Clara, CA) and a gradient 109 
elution (acetonitrile and 0.1% (v/v) formic acid). For minor compounds as ferruoylquinic acids, a 110 
75 mm × 4.6 mm,  2.6 μm Kinetex Phenyl Hexyl column equipped with SecurityGuard™ Ultra 111 
cartridges for Phenyl UHPLC (Phenomenex, Torrance, CA) and a similar elution gradient were 112 
used. Identification and quantitation of compounds were performed by external calibration of 113 
standard compounds on a 5-points calibration curve. 114 
Confirmation of the caffeine content in the regular and decaffeinated extracts was performed via the 115 
ISO 20481:2008 reference method, using a 1100 HPLC  system (Agilent, Waldbronn, Germany) 116 
equipped with a 4.6 mm × 150 mm,  5 μm MS-C18 XTerra column, isocratic elution of 117 
water/methanol 76/24, 10 μl injection volume and 272 nm detection wavelength. 118 
 119 
2.5. Antimicrobial activity assays for caffeine and for the regular and decaffeinated coffee 120 
extracts  121 
For the preparation of the stock solution of the regular and decaffeinated coffee extracts the 122 
lyophilized powder was resuspended in sterile Milli-Q water at a final concentration ranging from 123 
100 and 350 mg/ml for all the antimicrobial activity assays. For the caffeine stock a solution was 124 
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prepared dissolving 150 mg of caffeine powder (Sigma-Aldrich, St. Louis, MO) in 1 ml sterile 125 
Milli-Q water at 80°C.  126 
Minimum inhibitory concentration (MIC) values of the regular and decaffeinated coffee extracts 127 
and of caffeine were determined using the broth microdilution susceptibility test following the 128 
guidelines of the NCCLS with mid-log phase cultures. Serial two-fold dilutions of each extract or of 129 
caffeine were prepared in a final volume of 50 μl in 96-well polystyrene plates (Sarstedt, 130 
Nümbrecht, Germany) with MH broth. Each dilution series included control wells without the 131 
extract or without caffeine. A volume of 50 μl of a bacterial suspension at a concentration of 5 × 105 132 
cells/ml was then added to each well. The MIC was taken as the lowest concentration of regular and 133 
decaffeinated coffee extract or of caffeine resulting in the complete inhibition of visible growth 134 
after 20 h of incubation at 37°C. For the determination of the minimum bactericidal concentration 135 
(MBC) 25 μl of broth from clear wells were spotted in triplicate on a MH agar plate which was then 136 
incubated 20 h at 37°C. MBC was defined as the lowest concentration of coffee extract killing at 137 
least 99.99% of the original inoculum.  138 
To monitor bacterial growth inhibition, a bacterial suspension of 1 × 10
6
 cells/ml was grown in a 139 
96-well polystyrene plate (Sarstedt, Nümbrecht, Germany) with periodic shaking at 37°C in 140 
presence of 5 mg/ml coffee extract for E. coli, S. enterica and E. faecalis or in presence of 0.5 141 
mg/ml for S. aureus and S. epidermidis. The OD620 was measured on a microtiter plate reader 142 
(Tecan Trading AD, Männedorf, Switzerland) every 10 min for E. coli and S. enterica or every 30 143 
min for E. faecalis, S. aureus and S. epidermidis.  144 
For the viable colony count a bacterial suspension of 1 × 10
6
 cells/ml was grown with shaking at 145 
37°C in presence of 1, 2, 4 mg/ml coffee extract for S. aureus and S. epidermidis or in presence of 5 146 
mg/ml coffee extract for E. faecalis. At each time point (1, 2, 4 h) an aliquot of the sample was 147 
serially diluted in fresh MH broth and 25 μl of the serial dilutions were spotted in triplicate on a 148 
MH agar plate which was then incubated 20 h at 37°C to allow the viable colony count.  149 
 150 
 8 
2.5.1. Antimicrobial activity of the regular coffee extract in combination with vancomycin 151 
The activity of the regular coffee extract combined to vancomycin (Sigma-Aldrich, St. Louis, MO) 152 
was evaluated by the checkerboard technique in a 96-well polystyrene plate (Euroclone, Milan, 153 
Italy). Briefly, concentrations of vancomycin, ranging from 8 μM (12 μg/ml) to 0.125 μM (0.18 154 
μg/ml), and regular coffee extract, ranging from 6 mg/ml to 0.09 mg/ml for S. aureus and S. 155 
epidermidis or from 60 mg/ml to 0.93 mg/ml for E. faecalis, were combined in the standard MIC 156 
format along with a bacterial suspension at a concentration of 5 × 10
5
 cells/ml. The microplate was 157 
incubated 20 h at 37°C and then the fractional inhibitory concentration (FIC) index was calculated 158 
for each combination as follows: FIC index = Σ (FICA + FICB), where FICA is the MIC of 159 
compound A in combination/MIC of compound A alone, and FICB is MIC of compound B in 160 
combination/MIC of compound B alone. Synergy was defined for a FIC index of ≤ 0.5, indifference 161 
for a FIC index of > 0.5 to ≤ 4, and antagonism for a FIC index of > 4 (Eliopoulos, 1996).  162 
 163 
2.6. Cytotoxicity towards eukaryotic cells  164 
The human breast carcinoma cell line was purchased from the ECACC N°86012803 (MCF7) and 165 
cultured in Dulbecco’s modified Eagle’s (DMEM) High Glucose medium (Euroclone, Milan, Italy) 166 
supplemented with 10% (v/v) Fetal Bovine Serum (FBS) (Euroclone, Milan, Italy), 2 mM L-167 
glutamine (Euroclone, Milan, Italy) and penicillin (100 U/ml)-streptomycin (100 μg/ml) (Sigma-168 
Aldrich, St. Louis, MO).  169 
For the cytotoxicity assay, the MCF7 cells were seeded at a density of 20,000 cells per well, in a 170 
volume of 100 μl, in a 96-well polystyrene plate (Euroclone, Milan, Italy) and incubated at 37°C 171 
with 5% CO2. After 1 h, 2 h, 4 h, 24 h exposure to different extract concentrations (1, 2, 3, 4 mg/ml) 172 
in supplemented DMEM High Glucose medium, the adherent cells were washed with Phosphate 173 
Buffered Saline (PBS) (Sigma-Aldrich, St. Louis, MO) and 20 μl of 5 mg/ml 1-(4, 5-174 
Dimethylthiazol-2-yl)-3, 5-diphenylformazan (MTT) (Sigma-Aldrich, St. Louis, MO) were added 175 
to 100 μl supplemented DMEM High Glucose medium in each well. After 4 h incubation at 37°C 176 
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with 5% CO2, the culture medium supernatant was removed and the formazan was dissolved with 177 
10% (w/v) tert-octylphenoxy poly(oxyethylene) ethanol (IGEPAL) (Sigma-Aldrich, St. Louis, MO) 178 
in HCl 0.01 N overnight at 37°C. The absorbance at 620 nm was measured on a microtiter plate 179 
reader (Tecan Trading AD, Männedorf, Switzerland).  180 
For the 23 h recovery in fresh DMEM High Glucose medium after 1 h exposure to the extract, the 181 
cells were washed with PBS and then 100 μl of fresh medium were added to each well. Afterwards 182 
the microplate was incubated at 37°C with 5% CO2 for the additional 23 h and then MTT was added 183 
as described above.  184 
 185 
2.7. Statistical analysis  186 
The significance of differences among bacterial strains treated with increasing concentrations of 187 
coffee extract for the viable colony count was assessed using GraphPad Prism (GraphPad Software, 188 
La Jolla, CA) by the ANOVA multiple comparison test with Student-Newman-Keuls post test for 189 
the Staphylococci strains and by the Unpaired t-test for the E. faecalis strain. For the cytotoxicity 190 
assay towards breast adenocarcinoma MCF7 cells the significance of differences among the various 191 
treatments was assessed using GraphPad Prism by the ANOVA multiple comparison test with 192 
Student-Newman-Keuls post test.  193 
 194 
3. Results and Discussion 195 
 196 
3.1. Analysis of the regular and decaffeinated coffee extracts  197 
The relative content of trigonelline, 3-, 4-, 5-CQAs, 3,4-, 3,5-, 4,5-diCQAs and 3-, 4-, 5-FQAs of 198 
the regular and of the decaffeinated coffee extracts was determined by UHPLC-DAD. Results 199 
indicate that the concentrations of all these components did not differ significantly between the two 200 
coffee extracts and that the only difference was the relative content of caffeine (Table 1), which was 201 
almost undetectable in the decaffeinated coffee extract. As expected, the specificity of the solvent 202 
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used in the decaffeination process resulted in a remarkable decrease in the caffeine content only 203 
(Farah, de Paulis, Moreira, Trugo, & Martin, 2006) and this permits to put in evidence the role 204 
played by caffeine which is not yet fully disclosed  (Antonio et al., 2010; Almeida et al., 2012). 205 
 206 
3.2. Antimicrobial activity of the regular and decaffeinated coffee extracts  207 
The antimicrobial activity of a regular Arabica coffee extract was measured against three Gram-208 
positive and two Gram-negative bacterial strains. The results are expressed as the MIC values for 209 
the tested strains (Table 2) and showed that the extract was active against all the strains. As a 210 
general result Gram-positive bacteria showed a higher susceptibility to the extracts with respect to 211 
the Gram-negative ones. The only exception was represented by E. faecalis which showed a MIC 212 
value similar to that of the Gram-negative strains (Table 2). Results obtained with S. aureus and  E. 213 
faecalis  are in agreement with previous data obtained using brewed coffee samples (Daglia, et al., 214 
1994; Rufian-Henares & de la Cueva, 2009). Excluding E. faecalis, the overall higher sensitivity of 215 
the Gram-positive bacteria towards the extract could be due to the different composition of the 216 
bacterial cell envelope in Gram-negative and positive bacteria, the latter lacking a low-permeability 217 
barrier such as the outer membrane.  218 
To evaluate the role of caffeine in the antimicrobial activity of the regular coffee extract, a 219 
decaffeinated coffee extract  (see Materials and methods) was also tested in parallel with pure 220 
caffeine. The results showed that there are no differences between regular and decaffeinated 221 
Arabica coffee extracts in the ability to inhibit the bacterial growth (Table 2). Furthermore the MIC 222 
values for pure caffeine are much higher for all the tested bacterial strains than the caffeine 223 
concentration determined in the regular coffee extract at the MIC value, which is < 0.1 mg/ml 224 
(Table 1). These results are in agreement with those obtained by Manzhu Kang et al. who reported 225 
that in presence of 4 mg/ml caffeine E. coli failed to grow (Kang et al., 2012).  226 
These results highlight the predominant antibacterial effect of components other than caffeine in the 227 
extract. Indeed Daglia et al. pointed to α-dicarbonyl compounds as the main agents responsible for 228 
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the antibacterial activity of roasted coffee against Staphylococcus aureus and Streptococcus mutans 229 
(Daglia, et al., 2007). Moreover, other roasted coffee constituents including melanoidins (the final 230 
products of the Maillard reaction), polyphenols, trigonelline and both caffeic and protocatechuic 231 
acids have shown to exert antibacterial activity (Morales, Somoza, & Fogliano, 2012) Almeida et 232 
al., 2012). 233 
We then investigated the ability of the regular coffee extract to inhibit the bacterial growth even at 234 
concentrations lower than the MIC values (Figure 1). In presence of 0.3-0.5 × MIC values of the 235 
regular coffee extract all the tested bacterial strains showed a decreased growth rate. However the 236 
highest inhibition of the bacterial growth was observed for E. faecalis: the effect of the extract on 237 
the growth rate of this strain was significantly higher than that observed for E. coli or S. enterica, 238 
even though the MIC value was comparable for the three strains.  239 
To evaluate whether the extract has a bacteriostatic effect, we studied the short-term effect of the 240 
extract against S. aureus and S. epidermidis, which showed the highest susceptibility to the extract 241 
in terms of MIC values, and against E. faecalis to better understand the effect of the extract on the 242 
growth rate of this strain.  243 
Against both Staphylococci strains the extract showed a bacteriostatic effect which was appreciable 244 
already after 1 h incubation and became more pronounced after prolonged incubation time at all the 245 
tested concentrations, leading to a 2-log growth reduction after 4 h incubation at the maximum 246 
concentration tested (4 mg/ml) for both S. aureus and S. epidermidis (Figure 2). These results 247 
suggest that the antibacterial activity of the regular coffee extract is mainly bacteriostatic at short 248 
exposure time and becomes bactericidal only after prolonged incubation. To confirm this 249 
observation the MBC values were determined for both S. aureus and S. epidermidis. We found that 250 
the MBC correspond to the MIC values of the extract for each strain (data not shown), indicating 251 
that after prolonged incubation (20 h) the extract was able to kill bacteria. The observation that the 252 
extract becomes bactericidal only after prolonged incubation time might suggest that it has a non-253 
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lytic mechanism of action, which in contrast would have shown a strong and rapid bactericidal 254 
effect. However further studies will be required to clarify this point.  255 
On the opposite, the treatment of E. faecalis with 5 mg/ml extract produced a significant 256 
bacteriostatic effect only after 4 h exposure to the extract (Figure 2B). This result, taken together 257 
with the inhibition of the growth rate showed in Figure 1B, suggests  that the extract exhibits a 258 
delayed effect on this bacterial strain, beginning to significantly slow the bacterial growth and to 259 
affect the bacterial viability only after 4 h treatment.  260 
To test a potential synergic effect of the regular coffee extract in combination with an antibiotic 261 
often used to treat nosocomial severe methicillin-resistant S. aureus (MRSA) infections(Rayner & 262 
Munckhof, 2005), the antimicrobial activity of the extract was evaluated in combination with 263 
vancomycin. 264 
Given that vancomycin acts by inhibiting proper cell wall synthesis in Gram-positive bacteria, we 265 
investigated whether the regular coffee extract enhanced its activity. The FIC indexes showed that 266 
all combinations of regular coffee extract plus vancomycin did not exhibit any synergic effect 267 
against S. aureus nor S. epidermidis (0.5 < FIC index ≤ 4). Similar results were obtained also for the 268 
combination of regular coffee extract plus vancomycin against E. faecalis (0.5 < FIC index ≤ 4), 269 
suggesting that this antibiotic and the extract act independently one from each other. 270 
 271 
3.3. Cytotoxicity effect of the regular coffee extract  272 
The eventual toxicity of the regular coffee extract was assayed towards breast adenocarcinoma 273 
MCF7 cells (Figure 3), a cell line that is used as a model for cytotoxic studies of chemotherapeutic 274 
agents. At a 3 mg/ml concentration, corresponding to 1.5- and 3-fold the MIC value for S. aureus 275 
and S. epidermidis respectively, no significant toxicity was observed up to 4 h exposure to the 276 
extract (Figure 3A). At this concentration, a significant decrease in cell viability was detected only 277 
with a 24-h exposure. We further investigated the cytotoxicity of the extract after prolonged 278 
exposure time showing that until 1 mg/ml the extract does not exhibit any effect on the viability of 279 
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the cells even after 24 h incubation (Figure 3B), while at 2 and 4 mg/ml the extract showed a 280 
significant toxicity towards the MCF7 cells. However, when the cells were left for 23 h in fresh 281 
medium, after the 1-h exposure, no toxicity was observed at any of the tested concentrations (Figure 282 
3C), suggesting that, even if a damage might be produced by the extract after 1 h exposure, the cells 283 
are able to repair it during the next 23 h.  284 
Hydrogen peroxide, which in coffee is mainly formed by roasting products, was already shown to 285 
play an important role in the cytotoxicity of coffee extracts towards bovine aorta endothelial cells 286 
(Hegele, et al., 2009). This molecule might have a role also in cytotoxicity towards MCF7 cells and 287 
further experiments will be needed to clarify this mechanism.   288 
These data are encouraging considering that after 2 h exposure to the minimum concentration of 289 
coffee extract (1 mg/ml) a clear antibacterial effect is already appreciable for both S. aureus and S. 290 
epidermidis, while the toxicity towards the MCF7 cells begins to be significant only after 24 h 291 
exposure to a concentration which is 4-fold (4 mg/ml) that producing a significant bacteriostatic 292 
effect.  293 
 294 
4. Conclusions 295 
In conclusion, we showed that an Arabica regular coffee extract has a wide-spectrum antibacterial 296 
activity. The extract was effective against S. epidermidis, which represent the dominant species 297 
among the resident flora on hands, and has been shown to act as a reservoir for the transfer of 298 
genetic elements to enhance the pathogenicity of S. aureus (Diep et al., 2006). The two 299 
Staphilococci strains are often responsible of nosocomial infections resistant to the antibiotics 300 
commonly used. In this respect we propose the use of the regular coffee extract as a component for 301 
topical preparations to be used in healthcare units aimed at reducing the transmission of pathogens 302 
by hand contact. Furthermore the observed antimicrobial activity of the extract against E. faecalis 303 
and S. aureus might be promising also for its use as a food preservative. Indeed both bacterial 304 
species may be present in many food products and can cause toxinfections (Giraffa, 2002; 305 
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Hennekinne, De Buyser, & Dragacci, 2012). Overall the kinetics of activity of the coffee extract 306 
appear to be slower than that of other antimicrobials, with the extract showing mainly a 307 
bacteriostatic effect at short exposure times, a feature that may be useful to arrest growth of 308 
contaminant bacteria in food.  309 
Finally, we showed that the Arabica coffee extract at the antibacterial concentrations does not cause 310 
significant cytotoxic effects towards a model cell line. Therefore we believe that this kind of 311 
compound deserves to be further studied with the aim to develop antibacterials for topical use, as 312 
active components of hand washing preparations. 313 
 314 
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Figure captions 381 
 382 
Figure 1. Growth kinetics of different Gram-negative (A) and Gram-positive (B) bacterial 383 
strains in presence of the regular coffee extract. Bacterial suspensions of 10
6
 cells ml
-1
 were 384 
grown for 4 h (A) or 8 h (B) in absence (solid line) or in presence (dashed line) of the extract and 385 
the OD620 was recorded every 10 min (A) or 30 min (B). Results are the mean of three independent 386 
experiments ± SD. 387 
 388 
Figure 2. Viable colony counts of the Gram-positive strains exposed to the regular coffee 389 
extract. Bacteria were incubated for different hours in presence of different concentrations of the 390 
extract, serially diluted with MH Broth, and plated to allow the viable colony counts. The results are 391 
reported as CFU/ml (log scale) and represent the mean of three independent experiments ± SD. (A) 392 
* p<0.05, ** p<0.01, *** p<0.001 (ANOVA with Student-Newman-Keuls post test). (B) * p<0.05 393 
(Unpaired t-test). 394 
 395 
Figure 3. Cytotoxicity towards breast adenocarcinoma MCF7 cells. (A) Percentage of viable 396 
cells compared to the control (no coffee extract, 100%) after increasing incubation times with 3 397 
mg/ml extract (grey bars). (B) Percentage of viable cells compared to the control (no coffee extract, 398 
100%) after 24 h exposure. (C) Percentage of viable cells compared to the control (no coffee 399 
extract, 100%) after 1 h exposure and 23 h recovery in fresh medium. Results represent the mean ± 400 
SEM of at least two independent experiments each performed in triplicate. ** p<0.01, *** p<0.001 401 
vs untreated control (ANOVA with Student-Newman-Keuls post test). 402 
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Tables 
 
Table 1. Relative content of trigonelline, caffeine, 
chlorogenic and dichlorogenic acids, and 
ferruoylquinic acids in coffee extracts. 
 regular 
(mg/g) 
decaffeinated 
(mg/g) 
trigonelline 21 24 
caffeine 38 < 2  
caffeine
a
 36 1
 
3-CQA 11 11 
4-CQA 12 11 
5-CQA 21 22 
3,4-diCQA 0.4 0.3 
3,5-diCQA 0.1 0.1 
4,5-diCQA 0.3 0.1 
3-FQA 2.6 2.3 
4-FQA 0.7 1.2 
5-FQA 0.6 0.9 
a
Determined by the ISO 20481:2008 reference method. 
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Table 2. Sensitivity of different bacteria to total aqueous extracts 
obtained from Arabica coffee and to pure caffeine.  
  
MIC (mg/ml) 
a
  
  
regular  decaffeinated  caffeine 
S. aureus ATCC25923  2 2 > 25 
S. epidermidis ATCC12228  1 1 25 
E. faecalis ATCC29212  15 15 12 
E. coli ATCC25922 15 15 3 
S. enterica ATCC14028  15 15 > 25 
a
Results are representative of three independent experiments. 
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Figure graphics 
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Figure 2 
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Figure 3 
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